TerminatedPHASE1, PHASE2NCT02267408
Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin
Studying Congenital factor II deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- McMaster University
- Principal Investigator
- Sam Schulman, MD, PhDMcMaster University
- Intervention
- Warfarin adjustment using the Fearon algorithm(other)
- Enrollment
- 42 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2017
Study locations (1)
- Thrombosis Service, HHS-General Hospital, Hamilton, Ontario, Canada
Collaborators
Epitome Pharmaceuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02267408 on ClinicalTrials.gov